143 related articles for article (PubMed ID: 2476625)
1. Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol.
Greenberg S; Cantor E; Paul J
J Cardiovasc Pharmacol; 1989 Sep; 14(3):444-53. PubMed ID: 2476625
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the beta-adrenoceptor blocking activity of the Class Ic antiarrhythmic drug diprafenone in man.
Wagner F; Jähnchen E; Trenk D
Eur J Clin Pharmacol; 1989; 36(6):579-82. PubMed ID: 2570700
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the beta-adrenoceptor blocking property of diprafenone in rats: stereoselective interaction, subtype specificity, and sensitization.
Nanoff C; Schütz W
J Cardiovasc Pharmacol; 1991 Dec; 18(6):837-42. PubMed ID: 1725895
[TBL] [Abstract][Full Text] [Related]
4. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.
Groschner K; Lindner W; Schnedl H; Kukovetz WR
Br J Pharmacol; 1991 Mar; 102(3):669-74. PubMed ID: 1364837
[TBL] [Abstract][Full Text] [Related]
5. [Electrophysiologic and hemodynamic effects of the new anti-arrhythmia agent diprafenone].
Gülker H; Heuer H; Thale J; Behrenbeck T
Z Kardiol; 1987 Jul; 76(7):411-4. PubMed ID: 3673162
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies.
McLeod AA; Stiles GL; Shand DG
J Pharmacol Exp Ther; 1984 Feb; 228(2):461-6. PubMed ID: 6141285
[TBL] [Abstract][Full Text] [Related]
7. The differentiation of propafenone from other class Ic agents, focusing on the effect on ventricular response rate attributable to its beta-blocking action.
Faber TS; Camm AJ
Eur J Clin Pharmacol; 1996; 51(3-4):199-208. PubMed ID: 9010685
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the apparent irreversible beta-adrenoceptor antagonist Ro 03-7894 with propranolol in cardiac ventricular muscle by pharmacological and radioligand binding techniques.
Rankin A; Broadley KJ
Biochem Pharmacol; 1982 Apr; 31(7):1325-32. PubMed ID: 6124256
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the antiarrhythmic profile of the new class I agent diprafenone.
Gülker H; Thale J; Olbing B; Heuer H; Frenking B; Bender F
Arzneimittelforschung; 1985; 35(9):1387-93. PubMed ID: 4084340
[TBL] [Abstract][Full Text] [Related]
10. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
[TBL] [Abstract][Full Text] [Related]
11. Block of single cardiac Na+ channels by antiarrhythmic drugs: the effect of amiodarone, propafenone and diprafenone.
Kohlhardt M; Fichtner H
J Membr Biol; 1988 May; 102(2):105-19. PubMed ID: 2458471
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic activity and antiarrhythmic efficacy of CK-3579, a new class III antiarrhythmic agent with beta-adrenergic blocking properties.
Argentieri TM; Troy HH; Carroll MS; Doroshuk CM; Sullivan ME
J Cardiovasc Pharmacol; 1993 Apr; 21(4):647-55. PubMed ID: 7681912
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of diprafenone stereoenantiomers on cardiac Na+ channels.
Kohlhardt M; Fichtner H
Eur J Pharmacol; 1988 Oct; 156(1):55-62. PubMed ID: 2850211
[TBL] [Abstract][Full Text] [Related]
14. Single-dose interaction study of diprafenone HCl and propranolol HCl in healthy volunteers.
Hinderling PH; Tendolkar A; Dee CM; Barr WH; Seiberling M; Duerr H
J Clin Pharmacol; 1995 Jul; 35(7):721-9. PubMed ID: 7560253
[TBL] [Abstract][Full Text] [Related]
15. Influence of the new class I antiarrhythmic agent diprafenone on the end-systolic pressure-volume relationship (conductance technique).
Thormann J; Kramer W; Kremer P; Schlepper M
Cardiovasc Drugs Ther; 1989 Apr; 3(2):145-54. PubMed ID: 2487530
[TBL] [Abstract][Full Text] [Related]
16. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic stimulation modulates the sodium current block by propafenone in rat ventricular myocardium.
Maier SK; Kirstein M
J Electrocardiol; 2002 Oct; 35(4):343-9. PubMed ID: 12395362
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects of diprafenone, a dimethyl congener of propafenone on guinea-pig ventricular cells.
Kodama I; Suzuki R; Honjo H; Toyama J
Br J Pharmacol; 1992 Nov; 107(3):813-20. PubMed ID: 1335340
[TBL] [Abstract][Full Text] [Related]
19. Vasomolol: an ultra short-acting and vasorelaxant vanilloid type beta 1-adrenoceptor antagonist.
Lin YT; Wu BN; Wu JR; Lo YC; Chen LC; Chen IJ
J Cardiovasc Pharmacol; 1996 Jul; 28(1):149-57. PubMed ID: 8797149
[TBL] [Abstract][Full Text] [Related]
20. On the mechanism of drug-induced blockade of Na+ currents: interaction of antiarrhythmic compounds with DPI-modified single cardiac Na+ channels.
Kohlhardt M; Fichtner H; Fröbe U; Herzig JW
Circ Res; 1989 May; 64(5):867-81. PubMed ID: 2539922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
